Correction: Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
Main Authors: | Jessica A. Walsh, Christopher D. Saffore, Eric B. Collins, Andrew Ostor |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-11-01
|
Series: | Rheumatology and Therapy |
Online Access: | https://doi.org/10.1007/s40744-023-00626-1 |
Similar Items
-
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
by: Jessica A. Walsh, et al.
Published: (2023-08-01) -
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry
by: Martin J. Bergman, et al.
Published: (2022-11-01) -
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis
by: Victoria Navarro-Compán, et al.
Published: (2023-02-01) -
Symptomatic therapy for ankylosing spondylitis
by: Vladimir Vasilyevich Badokin
Published: (2012-03-01) -
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)